Calvenza-03 EIV

BOEHRINGER Calvenza-03 EIV Influenza - Single Dose
SKU : 21710
Price: $129.00

Equine influenza vaccine

  • 10 dose vial
  • Killed virus
  • On manufacturer backorder
by Boehringer

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease caused by equine influenza types A1 and A2 viruses.

Why Calvenza EIV?
  • Incorporates the emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95).Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93).
  • Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93).
  • Unique EHV-1 equine respiratory origin isolate.
  • Novel adjuvant.
  • Safe, all killed vaccine.
  • Includes innovative pliable nasal applicator.
  • Flexible dose administration.
  • No reversion to virulence concern.
  • Minimal vaccine site reactions.

Dosage and administration:

  • Shake well before use.
  • Using aseptic technique, inoculate horses intramuscularly with a 2ml dose.
  • Administer a third 2ml dose in 3-4 weeks by either the intramuscular or intranasal route.
  • Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.


All Vaccines Now Ship OVERNIGHT Delivery Only at a great LOW Rate!
Vaccines are shipped in a cooling package on Monday-Thursdays (on orders placed before 2:00p.m.)

Click here for Vaccine Shipping Schedule.

Customer Reviews
(0.00)
# of Ratings: 0

CALVENZA®-03 EIV

Boehringer Ingelheim

Equine Influenza Vaccine

Killed Virus

Indications: For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease caused by equine influenza types A2 North American and A2 Eurasian.

Administration and Dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 2 mL dose. Administer a second 2 mL dose intramuscularly in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks by either the intramuscular or intranasal route. Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.

Precautions: Store at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Preservative: Gentamicin.

For Veterinary Use Only

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506

U.S. Veterinary License No. 124

Code

 

 

132-515

1 Dose/2 mL

32501-00

132-535

10 Doses/20 mL

32504-00

NAC No.: 10281274

Loading...